Pathology revealed a pT2N3M0 lobular carcinoma, with positive estrogen receptor (ER, 70%) and progesterone receptor (PR, 80%) immunostainings, proliferative index (Ki67/MIB-1) as high as 15%, and negative HER2/neu status. This evidence concerns the gene PGR and breast lobular carcinoma.